1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Locations of primary tumors with respect to molecular groups
Subgroup Fourth Ventricle CPA (n = 6) (%) Paraventricular (n = 12) (%) Cerebellar Periphery (n = 19) (%) No. (n = 119) (%) Midline-Vermis (n = 40) (%) 4th-uniCPA (n = 25) (%) 4th-biCPA (n = 17) (%) Subtotal (n = 81) (%) WNT 15 (12.6) 5 (12.5) 3 (12) 1 (5.9) 8 (9.9) 3 (50) 3 (25) 0 (0) SHH 26 (21.8) 3 (7.5) 0 (0) 0 (0) 3 (3.7) 3 (50) 2 (16.7) 18 (94.7) Group 3 29 (24.4) 11 (27.5) 8 (32) 6 (35.3) 25 (30.9) 0 (0) 4 (33.3) 0 (0) Group 4 49 (41.2) 21 (52.5) 14 (56) 10 (58.8) 45 (55.5) 0 (0) 3 (25) 1 (5.3)
Note:—4th-uniCPA indicates fourth ventricle with unilateral extension along the lateral recess toward the CPA; 4th-biCPA, fourth ventricle with bilateral extension along bilateral recesses toward the CPAs.